Thursday, May 26, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Granules Receives Nod For Potassium Chloride For Oral Solution

Granules receives nod for potassium chloride for oral solution

By Telangana Today
Published: Published Date - 03:02 PM, Fri - 28 January 22

Hyderabad: Granules India said on Friday that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI)., a wholly owned foreign subsidiary of Granules India, for Potassium Chloride for Oral Solution USP, 20 mEq.

Potassium chloride is used to prevent or to treat low levels of potassium in blood (hypokalemia). It is bioequivalent to the reference listed drug product, Potassium Chloride for Oral Solution, 20 mEq, of Pharma Research Software Solution. The product would be available for the US market shortly.

Granules now have a total of 49 ANDA approvals from US FDA (47 Final approvals and 2 tentative approvals).

The current annual US market for Potassium Chloride for Oral Solution USP, 20 mEq is approximately $44 million (over Rs 330 crore), according to MAT Nov 2021, IQVIA/IMS Health.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • Abbreviated New Drug Application
  • Granules India
  • potassium chloride

Related News

  • Three Hyderabad firms to make generic version of Pfizer’s Covid drug

  • Granules India subsidiary completes USFDA audit

  • Granules Q3 net profit dips 31%

  • Granules’ US arm concludes FDA Audit with three minor observations

  • Granules appoints former Dr Reddy’s CFO as independent director

  • Granules Q2 net profit dips 51%

Latest News

  • Hyderabad adopts smart tech for sewage treatment

    7 hours ago
  • Opinion: Greek lessons for Asean nations

    7 hours ago
  • IPL 2022: Patidar’s 112 not out guides RCB to 14-run win over LSG

    7 hours ago
  • Upset woman ends life in Hyderabad

    8 hours ago
  • Editorial: Shed ambivalence on caste census

    8 hours ago
  • Using AI to predict heart episodes

    8 hours ago
  • Golf: Boulder Hills Tigers beat Boulder Raiders 2-1 in ATUM T9 Challenge

    8 hours ago
  • JNTU-Hyderabad to offer dual-degree

    8 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam